Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial infarction, persistent moderate left ventricular systolic dysfunction and ...
AtaCor Medical has enrolled the first patient in its ALARION-EV pivotal trial, which is evaluating an investigational ...
Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...
Sudden cardiac death is commonly caused by ventricular arrhythmias, which may be an abnormally fast heartbeat (ventricular tachycardia) or an irregular rhythm (ventricular fibrillation). The most ...
Madrid, Spain – 30 August 2025: Prophylactic implantable cardioverter defibrillator therapy did not reduce mortality in patients with a prior myocardial infarction, persistent moderate left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results